Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
PhoreMost
PhoreMost
Activities:
Research & Development
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
PhoreMost partners with Roche on multi-project drug target collab
PhoreMost will deploy its in-house expertise and next-generation phenotypic screening platform, SITESEEKER
Manufacturing
PhoreMost expands into Cambridge facility at Unity Campus
This relocation places the company in close proximity to numerous life science and technology organisations
Research & Development
NeoCura and PhoreMost announce collaboration on cancer therapeutics
As part of the collaboration, PhoreMost's Siteseeker phenotypic screening platform and NeoCura's full-process RNA drug design platform will be used
Pharmaceutical
PhoreMost fills Director roles with an OBE and a PhD
UK biopharma has appointed Dr Beech as a Non-Executive Director and Dr Cross as Senior Director of Technology
Drug Delivery
Boehringer chooses PhoreMost for new drug discovery collaboration
PhoreMost's Siteseeker platform will be deployed to identify novel targets for Boehringer’s programmes
Media
PhoreMost and o2h discovery collaborate
Collaboration will aim to progress first-in-class drug discovery programmes
Research & Development
Funding to support novel cancer immunotherapy programme
Award of the grant funds expanded operations and recognises innovative drug discovery programme
Subscribe now